The study of BDNF Val66Met polymorphism in Chinese schizophrenic patients

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 6, 2010, Pages 930-933

  Zhou, Dong Hao ^a   Yan, Quan Zhi ^b   Yan, Xiao Mei ^c   Li, Cun Bao ^b   Fang, Hui ^a   Zheng, You Lan ^c   Zhang, Chong Xi ^d   Yao, Hui Jun ^a   Chen, Da Chun ^e   Xiu, Mei Hong ^e   Kosten, Thomas R ^f   Zhang, Xiang Yang ^e,f  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b INNER MONGOLIA MEDICAL COLLEGE   (China)

^c JILIN AGRICULTURAL UNIVERSITY   (China)

^d SHANDONG UNIVERSITY   (China)

^e BEIJING HUILONGGUAN HOSPITAL   (China)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Age of onset; Association; Brain derived neurotrophic factor; Polymorphism; Schizophrenia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHIONINE; VALINE;

ADULT; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PHENOTYPE; POSITIVE AND NEGATIVE SYNDROME SCALE; SCHIZOPHRENIA; SYMPTOMATOLOGY; ANALYSIS OF VARIANCE; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; POLYMERASE CHAIN REACTION; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE OF ONSET; ANALYSIS OF VARIANCE; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 77955052384     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.04.019     Document Type: Article

References (26)

1. Bueller J.A., Aftab M., Sen S., Gomez-Hassan D., Burmeister M., Zubieta J.K. BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry 2006, 59:812-815.
2. Cardno A.G., Holmans P.A., Rees M.I., Jones L.A., McCarthy G.M., Hamshere M.L., et al. A genomewide linkage study of age at onset in schizophrenia. Am J Med Genet 2001, 105:439-445.
3. Chao H.M., Kao H.T., Porton B. BDNF Val66Met variant and age of onset in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:505-506.
4. Chen Q.Y., Chen Q., Feng G.Y., Wan C.L., Lindpaintner K., Wang L.J., et al. Association between the brain-derived neurotrophic factor (BDNF) gene and schizophrenia in the Chinese population. Neurosci Lett 2006, 397:285-290.
5. Dempster E., Toulopoulou T., McDonald C., Bramon E., Walshe M., Filbey F., et al. Association between BDNF Val66 Met genotype and episodic memory. Am J Med Genet B Neuropsychiatr Genet 2005, 134B:73-75.
6. Dluzen D.E., Gao X., Story G.M., Anderson L.I., Kucera J., Walro J.M. Evaluation of nigrostriatal dopaminergic function in adult +/+ and +/- BDNF mutant mice. Exp Neurol 2001, 170:121-128.
7. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., et al. The BDNF Val66Met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112:257-269.
8. Gourion D., Goldberger C., Leroy S., Bourdel M.C., Olié J.P., Krebs M.O. Age at onset of schizophrenia: interaction between brain-derived neurotrophic factor and dopamine D3 receptor gene variants. NeuroReport 2005, 16:1407-1410.
9. Hariri A.R., Goldberg T.E., Mattay V.S., Kolachana B.S., Callicott J.H., Egan M.F., et al. Brain-derived neurotrophic factor Val66Met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 2003, 23:6690-6694.
10. Ho B.C., Milev P., O'Leary D.S., Librant A., Andreasen N.C., Wassink T.H. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch Gen Psychiatry 2006, 63:731-740.
11. Ho B.C., Andreasen N.C., Dawson J.D., Wassink T.H. Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. Am J Psychiatry 2007, 164:1890-1899.
12. Kanazawa T., Glatt S.J., Kia-Keating B., Yoneda H., Tsuang M.T. Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder. Psychiatr Genet 2007, 17:165-170.
13. Liou Y.J., Liao D.L., Chen J.Y., Wang Y.C., Lin C.C., Bai Y.M., et al. Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophicfactor gene Val66Met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients. Neuromolecular Med 2004, 5:243-251.
14. Naoe Y., Shinkai T., Hori H., Fukunaka Y., Utsunomiya K., Sakata S., et al. No association between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and schizophrenia in Asian populations: evidence from a case-control study and meta-analysis. Neurosci Lett 2007, 415:108-112.
15. Nawa H., Takahashi M., Patterson P.H. Cytokine and growth factor involvement in schizophrenia - support for the developmental model. Mol Psychiatry 2000, 5:594-603.
16. Neves-Pereira M., Cheung J.K., Pasdar A., Zhang F., Breen G., Yates P., et al. BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry 2005, 10:208-212.
17. Neves-Pereira M., Mundo E., Muglia P., King N., Macciardi F., Kennedy J.L. The brain derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 2002, 71:651-655.
18. Numata S., Ueno S., Iga J., Yamauchi K., Hongwei S., Ohta K., et al. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms. Neurosci Lett 2006, 401:1-5.
19. Pezawas L., Verchinski B.A., Mattay V.S., Callicott J.H., Kolachana B.S., Straub R.E., et al. The brain-derived neurotrophic factor Val66Met polymorphism and variation in human cortical morphology. J Neurosci 2004, 24:10099-10102.
20. Poo M.M. Neurotrophins as synaptic modulators. Nat Rev Neurosci 2001, 2:24-32.
21. Rosa A., Cuesta M.J., Fatjó-Vilas M., Peralta V., Zarzuela A., Fañanás L. The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with risk for psychosis: evidence from a family-based association study. Am J Med Genet B Neuropsychiatr Genet 2006, 141B:135-138.
22. Szeszko P.R., Lipsky R., Mentschel C., Robinson D., Gunduz-Bruce H., Sevy S., et al. Brain-derived neurotrophic factor Val66Met polymorphism and volume of the hippocampal formation. Mol Psychiatry 2005, 10:631-636.
23. Tyler W.J., Perrett S.P., Pozzo-Miller L.D. The role of neurotrophins in neurotransmitter release. Neuroscientist 2002, 8:524-531.
24. Varnäs K., Lawyer G., Jönsson E.G., Kulle B., Nesvåg R., Hall H., et al. Brain-derived neurotrophic factor polymorphisms and frontal cortex morphology in schizophrenia. Psychiatr Genet 2008, 18:177-183.
25. Xu M.Q., St Clair D., Ott J., Feng G.Y., He L. Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population based study and meta-analysis. Schizophr Res 2007, 91:6-13.
26. Zintzaras E. Brain-derived neurotrophic factor gene polymorphisms and schizophrenia: a meta-analysis. Psychiatr Genet 2007, 17:69-75.